Central Retinal Artery Occlusion-A New, Provisional Treatment Approach
He told me recently, I feel like myself again. Thats what this is really about: enhancing overall well-being and improving quality of life
Betul Ibis and colleagues, used the TriNetX database to compare 217,302 diabetes patients on GLP-1 medications with 217,302 matched patients on DPP-4 inhibitors. Patients on GLP-1s had a significantly lower risk of developing rheumatoid arthritis (HR = 0.87, p = 0.026), gout, and osteoarthritis within one year
doi: 10.3389/fphar.2025.1617546 Received 24 April 2025 Accepted 21 July 2025 Published 31 July 2025 Volume 16 - 2025 Edited by Izolde Bouloukaki, University of Crete, Greece Reviewed by Maimaiti Tuniyazi, Jilin University, China zhiqiang Dou, Changchun University of Chinese Medicine, China Xue Wan, Mayo Clinic, United States Updates Copyright 2025 Lv, Zhang, Liu, Wang and Zhao